Inhibrx Biosciences, Inc. (INBX) Insider Trading

Name: Inhibrx Biosciences, Inc. (INBX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 28, 2026): Mark Lappe (Chief Executive Officer): Purchase of 3,324 shares, $328.6K.

Get alerted when insiders trade INBX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta